Sign In
Buy MDT
$85.39
-0.320 (-0.373%)
At Close: Jul 31, 2026
Medtronic shares fall after FDA advisors' lukewarm vote on blood-pressure treatment device
08:09am, Thursday, 24'th Aug 2023
Medtronic PLC shares MDT, -0.05% were down 1.3% premarket on Thursday after advisors to the U.S. Food and Drug Administration had a mixed reaction to the company's investigational renal denervation sy
US FDA panel votes against use of Medtronic's blood pressure treatment device
06:15pm, Wednesday, 23'rd Aug 2023
The U.S. Food and Drug Administration's independent experts on Wednesday narrowly voted against recommending the approval of Medtronic's blood pressure treatment device, saying risks tied to using it
MDT or PODD: Which Is the Better Value Stock Right Now?
12:47pm, Wednesday, 23'rd Aug 2023
Investors interested in Medical - Products stocks are likely familiar with Medtronic (MDT) and Insulet (PODD). But which of these two stocks offers value investors a better bang for their buck right n
Here are 13 stocks Jim Cramer is watching, including a big retailer earnings winner
09:56am, Wednesday, 23'rd Aug 2023
Here are some of the tickers on my radar for Wednesday, Aug. 23, taken directly from my reporter's notebook.
Medtronic (MDT) Q1 Earnings Beat Estimates, Margins Up (Revised)
07:31am, Wednesday, 23'rd Aug 2023
Strength across businesses and geographies, driven by execution, innovation, and improved underlying fundamentals contributes to Medtronic (MDT) Q1 revenues.
Medtronic to participate in upcoming investor conferences
06:16pm, Tuesday, 22'nd Aug 2023
DUBLIN , Aug. 22, 2023 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today confirmed its participation in the following upcoming investor conferences: 2023 Wells
Why Medtronic Stock Was a Winner Today
03:22pm, Tuesday, 22'nd Aug 2023
The medical device maker unveiled its results for the first quarter of fiscal 2024. It topped analyst estimates for both revenue and adjusted profitability.
Medtronic CEO: Our biggest driver is our diabetes business where we doubled growth
12:59pm, Tuesday, 22'nd Aug 2023
Geoffrey Martha, Medtronic Chairman and CEO, joins 'Squawk on the Street' to discuss the company's quarterly earnings results, the key drivers in the quarter and Medtronic's business in China.
Medtronic (MDT) Q1 Earnings Beat Estimates, Margins Down
12:02pm, Tuesday, 22'nd Aug 2023
Strength across businesses and geographies, driven by execution, innovation and improved underlying fundamentals, contributes to Medtronic's (MDT) Q1 revenues.
Medtronic (MDT) Reports Q1 Earnings: What Key Metrics Have to Say
10:31am, Tuesday, 22'nd Aug 2023
While the top- and bottom-line numbers for Medtronic (MDT) give a sense of how the business performed in the quarter ended July 2023, it could be worth looking at how some of its key metrics compare t
Medtronic (MDT) Surpasses Q1 Earnings and Revenue Estimates
09:46am, Tuesday, 22'nd Aug 2023
Medtronic (MDT) came out with quarterly earnings of $1.20 per share, beating the Zacks Consensus Estimate of $1.11 per share. This compares to earnings of $1.13 per share a year ago.
Will Medtronic (MDT) Beat Estimates Again in Its Next Earnings Report?
01:32pm, Monday, 21'st Aug 2023
Medtronic (MDT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
US FDA staff raise no concerns about Otsuka, Medtronic blood pressure devices
02:26pm, Friday, 18'th Aug 2023
The U.S. Food and Drug Administration (FDA) staff reviewers said on Friday they found no safety and effectiveness issues with devices made by Otsuka Holdings and rival Medtronic Plc for use in a blood
What's in the Cards for Medtronic (MDT) in Q1 Earnings?
02:04pm, Friday, 18'th Aug 2023
Strength across all businesses is likely to drive Medtronic's (MDT) first-quarter performance.
7 Blue-Chip Stocks Smart Investors Should Be Loading Up on Now
04:25pm, Monday, 14'th Aug 2023
There's a reasonable argument to be made that investors should load up on blue-chip stocks regularly. After all, large and well-established firms with long track records of success are likely to conti
